BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29900657)

  • 1. Improvement of S
    Kasai Y; Sato K; Utsumi S; Ichikawa S
    Chembiochem; 2018 Sep; 19(17):1866-1872. PubMed ID: 29900657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism-Based Inhibitor of DNA Cytosine-5 Methyltransferase by a S
    Sato K; Kunitomo Y; Kasai Y; Utsumi S; Suetake I; Tajima S; Ichikawa S; Matsuda A
    Chembiochem; 2018 Apr; 19(8):865-872. PubMed ID: 29392812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the recognition mechanism of DNA cytosine-5 methyltransferases (DNMTs) by incorporation of acyclic 5-fluorocytosine (
    Utsumi S; Sato K; Ichikawa S
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2189-2194. PubMed ID: 29752184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of inhibition of DNA (cytosine C5)-methyltransferases by oligodeoxyribonucleotides containing 5,6-dihydro-5-azacytosine.
    Sheikhnejad G; Brank A; Christman JK; Goddard A; Alvarez E; Ford H; Marquez VE; Marasco CJ; Sufrin JR; O'gara M; Cheng X
    J Mol Biol; 1999 Feb; 285(5):2021-34. PubMed ID: 9925782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site.
    van Bemmel DM; Brank AS; Eritja R; Marquez VE; Christman JK
    Biochem Pharmacol; 2009 Sep; 78(6):633-41. PubMed ID: 19467223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oligodeoxyribonucleotide containing 5-formyl-2'-deoxycytidine (fC) at the CpG site forms a covalent complex with DNA cytosine-5 methyltransferases (DNMTs).
    Sato K; Kawamoto K; Shimamura S; Ichikawa S; Matsuda A
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5395-5398. PubMed ID: 27780634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of NSC 106084 and NSC 14778 and evaluation of their DNMT inhibitory activity.
    Leroy M; Mélin L; LaPlante SR; Medina-Franco JL; Gagnon A
    Bioorg Med Chem Lett; 2019 Mar; 29(6):826-831. PubMed ID: 30704813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence-specific and mechanism-based crosslinking of Dcm DNA cytosine-C5 methyltransferase of E. coli K-12 to synthetic oligonucleotides containing 5-fluoro-2'-deoxycytidine.
    Hanck T; Schmidt S; Fritz HJ
    Nucleic Acids Res; 1993 Jan; 21(2):303-9. PubMed ID: 8441638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.
    Champion C; Guianvarc'h D; Sénamaud-Beaufort C; Jurkowska RZ; Jeltsch A; Ponger L; Arimondo PB; Guieysse-Peugeot AL
    PLoS One; 2010 Aug; 5(8):e12388. PubMed ID: 20808780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleosides and nucleotides. CXIX. Inhibition of DNA-cytosine methylase HhaI by a self-complementary oligonucleotide containing 5-fluorocytosine.
    Ono A; Matsuo Y; Matsuda A; Ueda T
    Biol Pharm Bull; 1993 Jun; 16(6):529-33. PubMed ID: 8364503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells.
    Pechalrieu D; Dauzonne D; Arimondo PB; Lopez M
    Eur J Med Chem; 2020 Jan; 186():111829. PubMed ID: 31757526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation.
    Kudo G; Hirao T; Harada R; Hirokawa T; Shigeta Y; Yoshino R
    Sci Rep; 2024 Jun; 14(1):13508. PubMed ID: 38866895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of DNA methyltransferases: insights from computational studies.
    Yoo J; Medina-Franco JL
    Curr Med Chem; 2012; 19(21):3475-87. PubMed ID: 22709005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 2-Amino-4-Fluoropyridine-C-Nucleoside Phosphoramidite for Incorporation into Oligonucleotides.
    Sato K; Matsuda A
    Curr Protoc Nucleic Acid Chem; 2019 Jun; 77(1):e77. PubMed ID: 30747492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 6-amino-2-vinylpurine derivatives for cross-linking and evaluation of the reactivity.
    Kusano S; Sakuraba T; Hagihara S; Nagatsugi F
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6957-61. PubMed ID: 23044366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a potential DNA methyltransferase (DNMT) inhibitor.
    Jan Z; Ahmed WS; Biswas KH; Jithesh PV
    J Biomol Struct Dyn; 2024 Jun; 42(9):4730-4744. PubMed ID: 37424222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTs.
    Yoo J; Choi S; Medina-Franco JL
    PLoS One; 2013; 8(4):e62152. PubMed ID: 23637988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the selective binding mechanism of DNMT1 and DNMT3A inhibitors: a molecular simulation study.
    Xie T; Yu J; Fu W; Wang Z; Xu L; Chang S; Wang E; Zhu F; Zeng S; Kang Y; Hou T
    Phys Chem Chem Phys; 2019 Jun; 21(24):12931-12947. PubMed ID: 31165133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling and virtual screening of DNA methyltransferase inhibitors.
    Medina-Franco JL; Yoo J
    Curr Pharm Des; 2013; 19(12):2138-47. PubMed ID: 23016844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling and molecular dynamics studies of hydralazine with human DNA methyltransferase 1.
    Singh N; Dueñas-González A; Lyko F; Medina-Franco JL
    ChemMedChem; 2009 May; 4(5):792-9. PubMed ID: 19322801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.